Literature DB >> 23877480

Executive function and cerebrovascular reactivity in pediatric hypertension.

Maria A Ostrovskaya1, Mary Rojas2, Juan C Kupferman3, Marc B Lande4, Kara Paterno3, Yuri Brosgol1, Steven G Pavlakis5.   

Abstract

Primary hypertension is associated with decreased performance on neurocognitive testing and a blunted cerebrovascular reactivity to hypercapnia. Parents of 14 children with hypertension and prehypertension completed the Behavior Rating Inventory of Executive Functions. Children underwent 24-hour ambulatory blood pressure monitoring and transcranial Doppler with reactivity measurement using time-averaged maximum mean velocity and end-tidal carbon dioxide during hypercapnia-rebreathing test. Comparing the reactivity slope for the patients to historical controls showed a statistically significant difference (t = -5.19, df = 13, P < .001), with lower slopes. Pearson correlations of the Behavior Rating Inventory of Executive Functions scores with the reactivity slopes showed a statistically significant inverse relationship with Behavioral Regulation Index (r = -.60, P = .02), Metacognition Index (r = -.40, P = .05), and the Global Executive Component (r = -.53, P = .05). Children with hypertension have decreased executive function, and this correlates to low transcranial Doppler-reactivity slopes, suggesting that the brain is a target organ in hypertensive children.
© The Author(s) 2013.

Entities:  

Keywords:  cognition; hypertension; transcranial Doppler

Mesh:

Substances:

Year:  2013        PMID: 23877480     DOI: 10.1177/0883073813494264

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  8 in total

Review 1.  Antihypertensives in Children and Adolescents.

Authors:  Craig Authement; Joshua Samuels; Joyce P Samuel
Journal:  Curr Hypertens Rep       Date:  2022-09-17       Impact factor: 4.592

Review 2.  Is the Brain an Early or Late Component of Essential Hypertension?

Authors:  John Richard Jennings; Matthew F Muldoon; Alan F Sved
Journal:  Am J Hypertens       Date:  2020-05-21       Impact factor: 2.689

Review 3.  Blood Pressure and Cognitive Function in Children and Adolescents.

Authors:  Marc B Lande; Juan C Kupferman
Journal:  Hypertension       Date:  2019-03       Impact factor: 10.190

Review 4.  Ambulatory Blood Pressure Monitoring in Children and Adolescents: a Review of Recent Literature and New Guidelines.

Authors:  Ian Macumber
Journal:  Curr Hypertens Rep       Date:  2017-10-25       Impact factor: 5.369

5.  Neurocognition in children with autosomal recessive polycystic kidney disease in the CKiD cohort study.

Authors:  Erum A Hartung; Matthew Matheson; Marc B Lande; Katherine M Dell; Lisa M Guay-Woodford; Arlene C Gerson; Bradley A Warady; Stephen R Hooper; Susan L Furth
Journal:  Pediatr Nephrol       Date:  2014-05-15       Impact factor: 3.714

6.  Design and methods of the NiCK study: neurocognitive assessment and magnetic resonance imaging analysis of children and young adults with chronic kidney disease.

Authors:  Erum A Hartung; Nina Laney; Ji Young Kim; Rebecca L Ruebner; John A Detre; Hua-Shan Liu; Christos Davatzikos; Guray Erus; Jimit J Doshi; Robert T Schultz; John D Herrington; Abbas F Jawad; Divya G Moodalbail; Ruben C Gur; Allison M Port; Jerilynn Radcliffe; Stephen R Hooper; Susan L Furth
Journal:  BMC Nephrol       Date:  2015-04-30       Impact factor: 2.388

7.  Under-recognition of pediatric hypertension diagnosis: Examination of 1 year of visits to community health centers.

Authors:  Anoosh Moin; Nivedita Mohanty; Yacob G Tedla; Allison J Carroll; Roxane Padilla; Craig B Langman; Justin D Smith
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-29       Impact factor: 3.738

8.  The relationship between chronic health conditions and cognitive deficits in children, adolescents, and young adults with down syndrome: A systematic review.

Authors:  Kellen C Gandy; Heidi A Castillo; Lara Ouellette; Jonathan Castillo; Philip J Lupo; Lisa M Jacola; Karen R Rabin; Kimberly P Raghubar; Maria M Gramatges
Journal:  PLoS One       Date:  2020-09-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.